Pfizer is in a unique position in its history with gushers of cash flowing in from everywhere.
Pfizer will use this cash to power future growth
through its drug pipeline, innovation, and acquisitions
,
which will secure promising returns and profitability for investors in the year ahead.
Pfizer is definitely one of the most attractive healthcare investments around.
I wrote this article myself, and it expresses my own opinions.
I am not receiving compensation for it (other than from Seeking Alpha).
I have no business relationship with any company whose stock is mentioned in this article.
– Since I rated Pfizer as a Strong Buy on the 8th of February 2021, the shares have returned 43% for investors.
– The company has reinvented itself, and is enjoying one of the best periods of its history.
– Valuation is compelling, and growth prospects are strong.
– The selling of its stake in GSK’s consumer healthcare venture will generate even more cash to power growth.